BAILLARGUES
France
6
2021-10-14
6
2023-10-24
These are the the leading inventors for applications assigned to MEDESIS PHARMA:
MEDESIS PHARMA based in BAILLARGUES, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Treatment and prevention of injury due to radiation exposure
#2 | 2018-07-19 β Patent 11,278,568 granted on 2022-03-22In situ preparation of cyano-bridged metal nanoparticles within a biocompatible reverse micellar system
#3 | 2017-02-09 β Patent 10,172,954 granted on 2019-01-08Use of a reverse-micellar system for delivering chelators of radionuclides and metals
#4 | 2015-02-19 β Patent 9,452,136 granted on 2016-09-27Reverse micelle system comprising nucleic acids and use thereof
#5 | 2013-03-14 β Patent 8,877,237 granted on 2014-11-04Reverse micelle system comprising nucleic acids and use thereof
#6 | 2013-02-28 β Patent 9,592,218 granted on 2017-03-14Reverse micelle system comprising metal ions and use thereof
Also check out MEDESIS PHARMA's (Baillargues, France) applicant profile with 4 patent applications submitted.
11547 β